Aberrant expression of X-linked genes RbAp46, Rsk4, and Cldn2 in breast cancer

Molecular Cancer Research

Volumn 5, Issue 2, 2007, Pages 171-181

  Thakur, Archana ^a   Rahman, K M Wahidur ^a,c   Wu, Jack ^a   Bollig, Aliccia ^a   Biliran, Hector ^a   Lin, Xiukun ^b   Nassar, Hind ^a   Grignon, David J ^a   Sarkar, Fazlul H ^a   Liao, Joshua D ^a,c  

^a WAYNE STATE UNIVERSITY   (United States)

^b INSTITUTE OF OCEANOLOGY   (China)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CANCER INVASION; CLDN2 GENE; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; RBAP46 GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RSK4 GENE; TUMOR SUPPRESSOR GENE; X CHROMOSOME;

ANIMALS; BREAST; BREAST NEOPLASMS; CARRIER PROTEINS; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, X; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, X-LINKED; HETEROZYGOTE DETECTION; HUMANS; MEMBRANE PROTEINS; MICE; NUCLEAR PROTEINS; ONCOGENE PROTEINS; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

MURINAE;

EID: 33947255648     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-06-0071     Document Type: Article

References (29)

1. Heard E, Clerc P, Avner P. X-chromosome inactivation in mammals. Annu Rev Genet 1997;31:571-610.
2. Lyon MF, Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature 1961;190:372-3.
3. Buller RE, Sood AK, Lallas T, Buekers T, Skilling JS. Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer. J Natl Cancer Inst 1999;91:339-46.
4. Liao DJ, Du QQ, Yu BW, Grignon D, Sarkar FH. Novel perspective: focusing on the X chromosome in reproductive cancers. Cancer Invest 2003;21:641-58.
5. Mitelman F. Chromosomes, genes, and cancer. CA Cancer J Clin 1994;44: 133-5.
6. Brown CJ. Role of the X chromosome in cancer. J Natl Cancer Inst 1996;88: 480-2.
7. Camargo M, Wang N. Cytogenetic evidence for the absence of an inactivated X chromosome in a human female (XX) breast carcinoma cell line. Hum Genet 1980;55:81-5.
8. Ghosh SN, Shah PN. Probable mechanism for the loss of Barr body in human female tumor with special reference to breast cancer. Med Hypotheses 1981;7: 1099-104.
9. Ghosh SN, Shah PN, Banerji AP. Loss of X-chromatin and X-chromosome activation in HeLa cells. Acta Cytol 1979;23:169-72.
10. Rajeswari S, Ghosh SN, Shah PN, Borah VJ. Barr body frequency in the human breast cancer tissue. A prospective study on its prognostic value and its correlation with specific oestradiol receptors. Eur J Cancer 1977;13:99-102.
11. Wang N, Cedrone E, Skuse GR, Insel R, Dry J. Two identical active X chromosomes in human mammary carcinoma cells. Cancer Genet Cytogenet 1990;46:271-80.
12. Buekers TE, Lallas TA, Buller RE. Xp22.2-3 loss of heterozygosity is associated with germline BRCA1 mutation in ovarian cancer. Gynecol Oncol 2000;76:418-22.
13. Kristiansen M, Langerod A, Knudsen GP, Weber BL, Borresen-Dale AL, Orstavik KH. High frequency of skewed X inactivation in young breast cancer patients. J Med Genet 2002;39:30-3.
14. Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast carcinoma in men: a population-based study. Cancer 2004;101:51-7.
15. Rudas M, Schmidinger M, Wenzel C, et al. Karyotypic findings in two cases of male breast cancer. Cancer Genet Cytogenet 2000;121:190-3.
16. Zhong C, Kinch MS, Burridge K. Rho-stimulated contractility contributes to the fibroblastic phenotype of Ras-transformed epithelial cells. Mol Biol Cell 1997;8:2329-44.
17. Gregg XT, Kralovics R, Prchal JT. A polymorphism of the X-linked gene IDS increases the number of females informative for transcriptional clonality assays. Am J Hematol 2000;63:184-91.
18. Thakur A, XH, Wang Y, Bollig A, Biliran H, Liao DJ. Role of X-linked genes in breast cancer. Breast Cancer Res Treat 2005;93:135-43.
19. Berns K, Hijmans EM, Mullenders J, et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 2004;428: 431-7.
20. Dummler BA, Hauge C, Silber J, et al. Functional characterization of human RSK4, a new 90-kDa ribosomal S6 kinase, reveals constitutive activation in most cell types. J Biol Chem 2005;280:13304-14.
21. Myers AP, Corson LB, Rossant J, Baker JC. Characterization of mouse Rsk4 as an inhibitor of fibroblast growth factor-RAS-extracellular signal-regulated kinase signaling. Mol Cell Biol 2004;24:4255-66.
22. Zhang TF, Yu SQ, Deuel TF, Wang ZY. Constitutive expression of Rb associated protein 46 (RbAp46) reverts transformed phenotypes of breast cancer cells. Anticancer Res 2003;23:3735-40.
23. 2-terminal kinase-dependent apoptosis and suppresses progressive growth of tumor xenografts in nude mice. Anticancer Res 2003;23: 4621-7.
24. Sirchia SM, Ramoscelli L, Grati FR, et al. Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells. Cancer Res 2005;65:2139-46.
25. McDonald HL, Gascoyne RD, Horsman D, Brown CJ. Involvement of the X chromosome in non-Hodgkin lymphoma. Genes Chromosomes Cancer 2000;28: 246-57.
26. Terracciano LM, Bernasconi B, Ruck P, et al. Comparative genomic hybridization analysis of hepatoblastoma reveals high frequency of X-chromosome gains and similarities between epithelial and stromal components. Hum Pathol 2003;34:864-71.
27. Van Dyke DL, Abraham JP, Maeda K, Weiss L, Poel M. Multiple active X chromosomes in myelofibrosis with myeloid metaplasia. Cancer Genet Cytogenet 1981;3:137-44.
28. Gilbert SL, Sharp PA. Promoter-specific hypoacetylation of X-inactivated genes. Proc Natl Acad Sci U S A 1999;96:13825-30.
29. el-Kassar N, Hetet G, Briere J, Grandchamp B. Clonality analysis of hematopoiesis in essential thrombocythemia: advantages of studying T lymphocytes and platelets. Blood 1997;89:128-34.